Post-Acute Sequelae of COVID-19 clinical trials in New York
11 active Post-Acute Sequelae of COVID-19 trials with a site in New York. Describe your situation to see which ones look like a fit.
- Long-Covid-19 Alleviation Through Learning Mindfulness Study
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Antiviral Clinical Trial for Long Covid-19
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
- Harnessing Optimism and Perseverance in the Face of Long COVID-EspaƱol
- Understanding the Long-term Impact of COVID-19 in Adults
- Fareon Open Label Device Clinical Trial
- DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
- NE3107 in Adults With Neurological Symptoms of Long COVID
- tVNS in Long COVID-19
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down ā and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest ā what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.